1. European Medicines Agency (EMEA) (2007) Final Report from the EMEA/CHMP-Think-Tank Group on Innovative Drug Development “Innovative Drug Development Approaches”. EMEA headquarters, London. Available at: http://www.emea.europa.eu/pdfs/human/itf/12731807en.pdf
2. Federal Drug Administration (FDA) (2006) Innovation/stagnation: critical path opportunities report. FDA Report, March 2006. Available at: http://www.fda.gov/oc/initiatives/criticalpath/reports/opp_report.pdf
3. Bretz F, Koenig F, Brannath W, Glimm E, Posch M (2009) Adaptive designs for confirmatory clinical trials. Stat Med 28(8):1181–1217
4. Koenig F, Brannath W, Bretz F, Posch M (2008) Adaptive Dunnett tests for treatment selection. Stat Med 27:1612–1625
5. EMEA (2008) Report on the EMEA-EFPIA Workshop on Adaptive Designs in Confirmatory Clinical Trials. EMEA Headquarters, London. Available at: http://www.emea.europa.eu/pdfs/conferenceflyers/report_adaptivedesigns.pdf